Long term use of topical interpheron alpha 2-b for recurrent conjunctival squamous neoplasia
- Luis Fernández-Vega Cueto
- Paula Verdaguer
- Juan Alvarez de Toledo
- M. Fideliz de la Paz
ISSN: 2171-4703
Année de publication: 2012
Volumen: 3
Número: 2
Pages: 90-95
Type: Article
D'autres publications dans: Journal of Emmetropia: Journal of Cataract, Refractive and Corneal Surgery
Résumé
CASE STUDY: An 80-year-old woman diagnosed with a recurring conjunctival squamous cell carcinoma treated by surgical excision of the lesion, ocular surface reconstruction and topical interferon alpha 2-b. DISCUSSION: Squamous cell carcinoma is the most frequent malignant tumour of the ocular surface. Surgical removal of the lesion is the traditional treatment for these tumours, but this technique has a high recurrence rate. Immunotherapy is the current alternative for these carcinomas. Recent studies have proven the effectivity of interferon against epithelial neoplasms of the ocular surface. We could consider life-long treatments with topic interferon depending on the clinical characteristics of the patient, as its side effects are uncommon